Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carl Sterritt Insider Profile
4 Followers
Carl Sterritt, Chief Executive Officer at Shield Therapeutics, holds 10.20M shares in Shield Therapeutics (Ticker: GB:STX).
Carl Sterritt Shield Therapeutics (STX)Chief Executive Officer
Shield Therapeutics (STX)
Chief Executive Officer
Ranked #16,658 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+173.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Carl Sterritt holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 24, 2018 - Sep 24, 2019
Return:+421.40%
The most profitable trade made by Carl Sterritt
Carl Sterritt's Trading History
List of latest transactions for each holding click on a transaction to see Carl Sterritt's performance on stock
You May Also Like
Carl Sterritt insider profile FAQ
What is the percentage of profitable transactions made by Carl Sterritt?
The percentage of profitable transactions made by Carl Sterritt is 50%.
What is the average return per transaction made by Carl Sterritt?
The average return per transaction made by Carl Sterritt is 173.70%.
What stocks does Carl Sterritt hold?
Carl Sterritt holds: GB:STX stocks.
What was Carl Sterritt’s latest transaction?
Carl Sterritt latest transaction was an Uninformative Sell of 1.86K.
What was Carl Sterritt's most profitable transaction?
Carl Sterritt’s most profitable transaction was an Informative Buy of GB:STX stock on September 24, 2018. The return on the trade was 421.40%.
What is Carl Sterritt's role in Shield Therapeutics?
Carl Sterritt's role in Shield Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.